News

Portfolio Companies
in the News

Synergy Spine Solutions® Receives FDA Approval for its Synergy Disc®, Expanding Cervical Disc Replacement Options for U.S. Patients

February 27, 2026

FDA Approves Updated Label for Miach Orthopaedics’ BEAR® Implant to Include Significantly Lower Risk of Osteoarthritis

January 14, 2026

ShiraTronics Announces Positive 12-Month Follow-Up Results from RELIEV-CM Pilot Study, Demonstrating Sustained Clinical Benefit with Investigational Implantable Neuromodulation Therapy for Chronic Migraine

September 16, 2025

HistoSonics Announces $2.25B Acquisition by Consortium of Top-Tier Investors

August 7, 2025

Real-World Evidence for Miach Orthopaedics’ BEAR® Implant Highlighted at AOSSM 2025

July 14, 2025

Neuros Medical raises $56M Series D to support nerve stim tech

July 9, 2025

HistoSonics’ Histotripsy System Demonstrates 90% Local Tumor Control at 12 Months in #HOPE4LIVER Trials

April 28, 2025

FDA Approves Expanded Use of Miach Orthopaedics’ BEAR® Implant

March 10, 2025

Sound Blade Medical Closes $16.5 Million Series A Financing to Advance the Development of Innovative Handheld Histotripsy Therapy

January 29, 2025

category

Medtech

Status

Current

headquarters

Halifax, Nova Scotia

website

Sound Blade Medical

Sound Blade Medical is a medical device company that is developing handheld ultrasound-guided histotripsy technology to treat a wide range of conditions. Histotripsy is a non-invasive, non-thermal ablation technology to selectively destroy tissue with unparalleled precision.

category

medtech

status

Current

headquarters

Plymouth, Minnesota

website

HistoSonics

HistoSonics has developed a system to destroy tumors completely non-invasively. Treatment is achieved using histotripsy, a novel form of energy that is safe, extremely precise, and able to be personalized for each patient. The initial indication is for treatment of liver tumors and the system is being studied in several other types of tumors.

category

MEDTECH

status

Exited/Public

headquarters

Redwood City, California

website

Gynesonics

Gynesonics is a medical device company committed to advancing women’s health by developing transcervical, uterus-preserving, incisionless technologies for diagnostic and therapeutic applications. The company’s Sonata system is the world’s first and only intrauterine fibroid ablation system clinically proven to reduce fibroid symptoms across a wide range of fibroid types, sizes, and uterine locations.